SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-22-001412
Filing Date
2022-08-25
Accepted
2022-08-25 07:30:56
Documents
4
Period of Report
2022-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K liminalbio6k.htm 6-K 12914
2 PRESS RELEASE DATED AUGUST 25, 2022 ex991.htm EX-99.1 10821
3 FORM 51-102F3 MATERIAL CHANGE REPORT ex992.htm EX-99.2 11434
4 GRAPHIC logo.jpg GRAPHIC 8547
  Complete submission text file 0001279569-22-001412.txt   48170
Mailing Address 440 ARMAND-FRAPPIER BLVD. SUITE 300 LAVAL A8 H7V 4B4
Business Address 231 DUNDAS STREET EAST BELLEVILLE A6 K8N 1E2 450-781-0115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 221192978
SIC: 2834 Pharmaceutical Preparations